University of Leeds

A synthetic chemical (KHS101) has been discovered by researchers that has the ability to kill aggressive brain tumour cells by removing their source of energy. more


In this article, Dr Malcolm Haddrick (Medicines Discovery Catapult) and Professor Steve Evans (University of Leeds) highlight the exciting and innovative new method of drug delivery — microbubbles. more

, Opinion

A new research project between Medicines Discovery Catapult and the University of Leeds has started at Alderley Park, to bring microbubble technology a step closer to being used in patients. more


A recent study, published in Nature Communications, has described how a candidate synthetic vaccine for polio has been developed with a method grown in plants that use virus like particles (VLPs). more


University of Leeds researchers are part of the £20.4m Advanced Digital Design of Pharmaceutical Therapeutics (ADDoPT) programme introducing digital design processes to the pharmaceutical industry more


Aesica has announced its second major innovation board partnership following the recent annual Genesis conference, a famed hotbed of future innovation. more